| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.58 | 0.0001 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.57 | 0.0006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.45 | 0.006 |